Fluticasone Propionate EP Impurity J: Chemical Profile, Analytical Significance, and Quality Control Applications

In pharmaceutical development, maintaining the quality of an active pharmaceutical ingredient involves more than confirming its identity and measuring its assay value. Scientists must also understand the related substances that may be present during manufacturing, purification, storage, and formulation. This is particularly important for corticosteroids, where reliable impurity profiling supports product development and routine quality control.

Fluticasone propionate is a synthetic corticosteroid used in medicines for inflammatory and allergic conditions, including asthma and allergic rhinitis. Its pharmaceutical quality is assessed through a combination of identity testing, assay determination, impurity monitoring, and stability studies. Analytical laboratories therefore require suitable reference materials to identify and evaluate individual compounds associated with the active ingredient.

Fluticasone Propionate EP Impurity J, also known as Fluticasone Thioacid Impurity, is a related compound used in pharmaceutical impurity analysis. It is relevant to laboratories investigating fluticasone propionate-related substances and developing analytical methods for quality assessment.

For researchers seeking a dedicated reference material, Chemicea provides Fluticasone Propionate EP Impurity J for pharmaceutical analytical and research applications.

Understanding Fluticasone Propionate and Its Related Substances

Fluticasone propionate belongs to the corticosteroid class of pharmaceutical compounds. Its chemical structure contains a steroid framework with fluorine-containing substituents and a sulfur-containing functional group. These structural features contribute to the compound's properties and are important when developing analytical methods for its related substances.

During active pharmaceutical ingredient manufacturing, related compounds can arise from starting materials, intermediates, incomplete reactions, side reactions, or purification processes. Other substances may appear during storage or under specific environmental conditions. Their formation depends on the manufacturing route, processing conditions, formulation, and stability characteristics.

Not every related compound has the same origin or analytical significance. Some are process-related impurities, while others are associated with degradation or chemical transformation. Understanding these differences helps analytical scientists investigate the source of an observed chromatographic peak rather than treating every additional signal as the same type of impurity.

Fluticasone propionate impurity profiling may involve high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and, where appropriate, mass spectrometry or other structural characterization techniques. Published research has demonstrated the application of chromatographic methods to investigate fluticasone propionate-related substances in pharmaceutical materials and formulations.

What Is Fluticasone Propionate EP Impurity J?

Fluticasone Propionate EP Impurity J is a named fluticasone propionate-related compound listed by Chemicea under the category of impurity standards. The product is also identified by the synonym Fluticasone Thioacid Impurity.

Its chemical identity is described as:

6α,9-Difluoro-17-[(fluoromethoxy)carbonothioyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl propanoate.

The product information provides the following details:

Product name: Fluticasone Propionate EP Impurity J

Synonym: Fluticasone Thioacid Impurity

Chemicea catalogue number: CP-F23037

Molecular formula: C₂₅H₃₁F₃O₅S

Molecular weight: 500.57 g/mol

CAS number: Not available in the listed product information

Availability: Custom synthesis

Product category: Impurity Standards

These identifiers help researchers specify the material required for their analytical work. The molecular formula and molecular weight are useful during analytical preparation and mass spectrometric investigations, while the catalogue number helps laboratories communicate their requirements accurately.

The product's designation as EP Impurity J identifies it within a named impurity framework. Researchers should consult the applicable current European Pharmacopoeia documentation and their approved analytical procedures to establish the precise requirements relevant to a particular study.

Why Is Impurity J Relevant to Pharmaceutical Analysis?

The significance of an impurity reference material depends on the analytical question being investigated. In the case of Fluticasone Propionate EP Impurity J, a defined reference material can support investigations into the separation, identification, and measurement of a specific fluticasone-related compound.

One important application is chromatographic method development. A laboratory may need to determine whether its analytical procedure can distinguish the target impurity from the principal drug substance and other related compounds. Without suitable reference materials, interpreting individual peaks can be more difficult, particularly when several compounds have similar structural features.

A second application involves peak identification. When an additional signal appears in a chromatogram, analysts must establish whether it corresponds to a known related substance, an unknown degradation product, a sample-preparation artefact, or interference from the formulation. Comparison with a properly characterized reference material can provide useful evidence for peak assignment.

Impurity reference materials can also contribute to method validation, stability investigations, and pharmaceutical development. Their use does not automatically establish the identity or concentration of a compound; appropriate analytical procedures, system suitability, and supporting evidence remain necessary.

Role in HPLC and UPLC Method Development

HPLC remains a widely used technique for evaluating pharmaceutical related substances because it can separate multiple components within a sample and provide quantitative data when the method is appropriately developed and validated.

In a typical impurity profiling study, the analytical team evaluates the separation of the active ingredient from known impurities and potential degradation products. Chromatographic conditions may include a suitable stationary phase, mobile-phase composition, gradient programme, flow rate, column temperature, and detection wavelength.

A reference material such as Fluticasone Propionate EP Impurity J may be used to assess its retention behaviour under the selected conditions. The analyst can then investigate whether the compound is adequately resolved from neighbouring peaks and whether the procedure is sufficiently sensitive for the intended purpose.

UPLC offers another option for impurity analysis, particularly where faster separations or improved chromatographic efficiency are desirable. However, a method developed on one chromatographic platform should not automatically be considered equivalent to a method on another. Changes in column dimensions, particle size, flow rate, and system characteristics may affect separation performance.

For laboratories working with low-level impurities, peak resolution is especially important. Co-elution can compromise identification and quantification, even when the overall chromatogram appears satisfactory. Reference materials help analysts evaluate these risks during method development.

Identification and Structural Characterization

Retention time alone is generally insufficient to establish the definitive identity of an unknown compound. A peak may elute at a similar time to a reference substance without necessarily representing the same chemical species.

For this reason, impurity investigations may combine chromatographic comparison with complementary analytical techniques.

Liquid chromatography–mass spectrometry (LC-MS) can provide information about molecular mass and fragmentation patterns. These data help researchers assess whether a proposed identity is consistent with the observed analytical results.

Nuclear magnetic resonance (NMR) spectroscopy can provide structural information when sufficient purified material is available. It may help clarify molecular connectivity and distinguish between compounds that cannot be confidently differentiated through retention data alone.

Photodiode array detection (PDA) can assist with evaluating ultraviolet absorption characteristics and chromatographic peak purity, although spectral similarity does not independently prove structural identity.

The technique selected depends on the study objective, available instrumentation, quantity of material, and complexity of the sample. In some investigations, a combination of chromatographic and spectroscopic evidence is required to establish a reliable identification.

A published study in the Journal of Pharmaceutical and Biomedical Analysis demonstrated the use of coupled HPLC-NMR and HPLC-MS techniques to characterize impurities in fluticasone propionate bulk drug batches. This illustrates the value of complementary analytical evidence when investigating related compounds.

Application in Stability Studies

Pharmaceutical stability studies examine how the quality of a drug substance or product changes under defined storage conditions over time. These investigations help establish appropriate storage conditions, shelf life, and other quality-related parameters.

For fluticasone propionate, impurity profiling can help researchers observe changes in the chromatographic profile during stability testing. The appearance of a new peak, an increase in an existing peak, or a change in the principal compound's assay may indicate a need for further investigation.

A stability-indicating method should distinguish the active ingredient from relevant degradation products and other components that may interfere with measurement. Forced degradation studies can help evaluate whether the analytical method remains selective when the sample is exposed to appropriately designed stress conditions.

Fluticasone Propionate EP Impurity J may be relevant when a study specifically investigates this compound or requires its comparison with a sample component. Its actual role in a particular degradation pathway must be established using suitable experimental evidence; the impurity designation alone does not demonstrate that it forms under every stress condition.

Reference materials can therefore support a more systematic interpretation of stability data, provided their identity, suitability, and use are documented.

Importance in Pharmaceutical Quality Control

Quality-control laboratories need analytical procedures that produce consistent and interpretable results across different batches and testing occasions. Impurity testing contributes to this process by helping analysts detect and evaluate related substances within the scope of the applicable specification.

A suitable impurity reference material may support several laboratory activities:

Peak assignment: Comparing a sample peak with the chromatographic behaviour of the reference material.

Method development: Assessing whether the target compound can be separated from the active ingredient and other related substances.

Method validation: Supporting evaluation of specificity, precision, accuracy, linearity, range, and other relevant characteristics, as applicable.

Stability assessment: Investigating a compound when it is relevant to the observed changes in a sample.

Documentation: Providing traceable identification details for analytical procedures, reports, and laboratory records.

The precise use of a reference material depends on its assigned status and documentation. Laboratories should verify purity, characterization, storage requirements, expiry or retest information, and suitability for the intended purpose before using a material in regulated testing.

A reference material should not be assumed to be a certified reference standard simply because it is described as an impurity standard. Its documentation and assigned characteristics determine how it can appropriately be used.

Regulatory Considerations and Documentation

Pharmaceutical impurity control is an important part of quality assessment and regulatory documentation. Requirements depend on the substance, dosage form, analytical procedure, applicable pharmacopoeial monograph, and relevant regulatory framework.

When a laboratory works with a pharmacopoeial impurity designation, it should verify the current official requirements rather than relying exclusively on a supplier's product description. The laboratory should also confirm whether a particular material is intended for identification, quantitative analysis, research, or another defined purpose.

Analytical procedures should be appropriately validated or verified for their intended application. Documentation commonly includes the method version, instrument details, reference material identification, preparation records, system suitability results, calculations, chromatograms, and investigation records where applicable.

For regulated pharmaceutical work, the relationship between a reference material and the official method must be established from the relevant documentation. The presence of a named impurity standard does not, by itself, establish compliance with a pharmacopoeial specification.

Selecting a Suitable Fluticasone Propionate Impurity Standard

Before obtaining a reference material, analytical scientists should define the intended application. A standard selected for qualitative peak identification may have different documentation requirements from one intended for quantitative testing.

Several points deserve attention:

Chemical identity: Confirm the full compound name, synonym, molecular formula, and other available identifiers.

Analytical purpose: Establish whether the material is needed for method development, peak identification, stability testing, or quantitative analysis.

Documentation: Review the available certificate of analysis, characterization data, purity information, and relevant handling instructions.

Quantity requirements: Estimate the amount needed for initial method development, repeat testing, and planned validation activities.

Storage and handling: Follow the supplier's instructions and the laboratory's approved procedures to maintain material suitability.

For procurement and product-specific information, researchers can visit the Chemicea Fluticasone Propionate EP Impurity J product page. The listing identifies the compound as catalogue number CP-F23037 and indicates custom synthesis availability. Researchers should confirm current specifications, documentation, lead time, and supply conditions directly with the supplier before placing an order.

Frequently Asked Questions

1. What is Fluticasone Propionate EP Impurity J?

Fluticasone Propionate EP Impurity J is a named fluticasone propionate-related compound, also known as Fluticasone Thioacid Impurity. It is listed by Chemicea in its impurity standards category for pharmaceutical analytical and research applications.

2. What is the molecular formula of Fluticasone Propionate EP Impurity J?

The Chemicea product listing gives the molecular formula as C₂₅H₃₁F₃O₅S and the molecular weight as 500.57 g/mol.

3. What is the catalogue number of this impurity standard?

The Chemicea catalogue number is CP-F23037. The product page lists its availability as custom synthesis.

4. How can this impurity be used in HPLC analysis?

A suitably characterized reference material may help analysts evaluate retention behaviour, peak separation, and identification of the target compound during method development. Quantitative use requires appropriate documentation and a suitable analytical procedure.

5. Is the CAS number available?

The Chemicea product listing currently displays the CAS number as unavailable. Researchers should confirm whether an updated identifier or additional characterization information is available from the supplier.

6. Can this compound be used in stability studies?

It may be useful when the analytical objective involves investigating or identifying this specific compound. Its presence or formation under particular storage or stress conditions must be demonstrated experimentally.

7. Where can researchers obtain product information?

Researchers can consult the Chemicea product page for Fluticasone Propionate EP Impurity J to review the available identifiers and submit an enquiry about custom synthesis.

Conclusion

Fluticasone Propionate EP Impurity J is a specifically identified related compound that may be relevant to pharmaceutical impurity profiling, chromatographic method development, and investigations involving fluticasone propionate. Its value in an analytical workflow depends on the question being studied, the quality of the reference material documentation, and the suitability of the selected method.

HPLC and UPLC can support separation and measurement, while techniques such as LC-MS and NMR may provide additional evidence when structural identification is required. In every case, the results should be interpreted using validated procedures and appropriate scientific documentation.

For pharmaceutical researchers and analytical laboratories requiring this compound, Chemicea lists Fluticasone Propionate EP Impurity J (CP-F23037) with custom synthesis availability.